Page 21 - 2019 Annual Report | ECP
P. 21

    Geng, X., Irvin, M. R., Hidalgo, B., Aslibekyan, S., Srinivasasainagendra, V., An, P., . Straka, R. J., . . Zhi, D. (2019). An Exome-Wide Sequencing Study of the GOLDN Cohort Reveals Novel Associations of Coding Variants and Fasting Plasma Lipids. Frontiers in genetics, 10, 158.
   Graber, M. L., Grice, G. R., Ling, L. J., Conway, J. M., & Olson, A. (2019). Pharmacy Education Needs to Address Diagnostic Safety. American journal of pharmaceutical education, 83(6), 7442.
   Grant, M. K., Seelig, D. M., Sharkey, L. C., Choi, W. S., Abdelgawad, I. Y., & Zordoky, B. N. (2019). Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice. PLOS ONE, 14(2), e0212486.
   Hu, Z., Barkley, C. M., Marino, S. E., Wang, C., Rajan, A., Bo, K., . . . Ding, M. (2019). Working Memory Capacity Is Negatively Associated with Memory Load Modulation of Alpha Oscillations in Retention of Verbal Working Memory. Journal of Cognitive Neuroscience, 31(12), 1933-1945.
   Jakubík, J., Randáková, A., El-Fakahany, E. E., & Doležal, V. (2019). Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators. PloS one, 14(3), e0214255.
   Jakubík, J., Randáková, A., Rudajev, V., Zimčík, P., El-Fakahany, E. E., & Doležal, V. (2019). Applications and limitations of fitting of the operational model to determine relative efficacies of agonists. Scientific reports, 9(1), 4637.
   Johnson, P. H., Weinreb, N. J., Cloyd, J. C., Tuite, P. J., & Kartha, R. V. (2019). GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies. Molecular Genetics and Metabolism.
   Kapur, J., Elm, J., Chamberlain, J., Barsan, W., Cloyd, J. C., Lowenstein, D., . . . Sillbergleit, R. (2019). Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus,. NEJM, 381(22), 2103-2113. Date Accepted: November 2019
   Kartha, R. V., Joers, J., Terluk, M. R., Travis, A., Rudser, K., Tuite, P. J., . . . Öz, G. (2019). Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy. Journal of inherited metabolic disease.
   Kartha, R. V., Joers, J., Terluk, M., Tuite, P., Mishra, U., Rudser, K., . . . Cloyd, J. C. (2019). Preliminary N-acetylcysteine results for LDN 6722 - Role of oxidative stress and inflammation in Gaucher disease type 1: Potential use of antioxidant anti-inflammatory medications. Molecular Genetics and Metabolism, 126(2), S82.
   King, P. K., Fosnight, S. M., & Bishop, J. R. (2019). Consensus Clinical Decision-Making Factors Driving Anticoagulation in Atrial Fibrillation. The American Journal of Cardiology, 124(7), 1038--1043.
   Knight-Perry, J., Jennissen, C., Long, S. E., Hage, S., DeFor, T. E., Chan, W. T., . Kirstein, M. N., . . Smith, A. R. (2019). A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation. Bone marrow transplantation.
   Layek, B., Rahman, S. N., Rathi, S., Kandimalla, K. K., Wiedmann, T. S., & Prabha, S. (2019). Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery. AAPS PharmSciTech, 20(2), 58.
  20





















































































   19   20   21   22   23